Aquestive Therapeutics (AQST) Non-Current Deffered Revenue (2019 - 2026)
Aquestive Therapeutics' Non-Current Deffered Revenue was $18.85 million in Q2 2026, down 5.5% from $19.94 million a year earlier and down 1.4% from the prior quarter.
Powered by 
Analysis
Aquestive Therapeutics (AQST) Non-Current Deffered Revenue (2019 - 2026) Analysis & Trends
At the end of FY2025, Non-Current Deffered Revenue at Aquestive Therapeutics came in at $19.39 million, down 3.1% from FY2024.
- Non-Current Deffered Revenue shows a five-year compound annual growth rate of 39.8% (FY2020 to FY2025).
- In earlier years, Non-Current Deffered Revenue was $20.01 million in FY2024 (-38.2%), $32.35 million in FY2023 (+3.0%), $31.42 million in FY2022 (+341.1%) and $7.12 million in FY2021 (+96.0%).
- The Q2 2026 figure marks the lowest quarterly Non-Current Deffered Revenue since Q3 2022.
- Compared with a year earlier, Non-Current Deffered Revenue has declined for ten straight quarters, with an average decline of 17.2% over the last eight quarters.
- The best year-over-year quarter for Non-Current Deffered Revenue over five years was Q4 2022 (growth of 341.1%); the worst was Q1 2025 (a decline of 38.2%).
- Per Business Quant data, AQST's Non-Current Deffered Revenue in the three quarters before Q2 2026 was $19.12 million (Q1 2026), $19.39 million (Q4 2025) and $19.66 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | - |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | - |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | - |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | - |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | - |
| 10 | Aquestive Therapeutics | 557.27 Mn | 97.82 Mn | 9.80 Mn | 18.85 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 18.85 Mn |
| Mar 31, 2026 | 19.12 Mn |
| Dec 31, 2025 | 19.39 Mn |
| Sep 30, 2025 | 19.66 Mn |
| Jun 30, 2025 | 19.94 Mn |
| Mar 31, 2025 | 19.74 Mn |
| Dec 31, 2024 | 20.01 Mn |
| Sep 30, 2024 | 20.27 Mn |
| Jun 30, 2024 | 21.76 Mn |
| Mar 31, 2024 | 31.96 Mn |
| Dec 31, 2023 | 32.35 Mn |
| Sep 30, 2023 | 32.73 Mn |
| Jun 30, 2023 | 33.12 Mn |
| Mar 31, 2023 | 33.04 Mn |
| Dec 31, 2022 | 31.42 Mn |
| Sep 30, 2022 | 17.62 Mn |
| Jun 30, 2022 | 13.49 Mn |
| Mar 31, 2022 | 13.89 Mn |
| Dec 31, 2021 | 7.12 Mn |
| Sep 30, 2021 | 7.32 Mn |
API Access
Aquestive Therapeutics Non-Current Deffered Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=AQST&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-deffered-revenue", "ticker": "AQST", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=AQST&period=max&api_key=YOUR_API_KEY");
const data = await res.json();